Literature DB >> 30930333

Exploitation of the neural-hematopoietic stem cell niche axis to treat myeloproliferative neoplasms.

Naoimh Herlihy1, Claire N Harrison2, Donal P McLornan1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30930333      PMCID： PMC6442959          DOI： 10.3324/haematol.2018.211896

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  25 in total

Review 1.  Myeloproliferative neoplasm stem cells.

Authors:  Adam J Mead; Ann Mullally
Journal:  Blood       Date:  2017-02-03       Impact factor: 22.113

2.  Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms.

Authors:  M A Avanzini; M E Bernardo; F Novara; M Mantelli; V Poletto; L Villani; E Lenta; D M Ingo; V Achille; E Bonetti; M Massa; R Campanelli; G Fois; P Catarsi; R P Gale; A Moretta; A Aronica; R Maccario; G Acquafredda; D Lisini; M Zecca; O Zuffardi; F Locatelli; G Barosi; V Rosti
Journal:  Leukemia       Date:  2014-03-12       Impact factor: 11.528

Review 3.  Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond.

Authors:  Claire N Harrison; Donal P McLornan
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

5.  A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency.

Authors:  Carl R Walkley; Gemma Haines Olsen; Sebastian Dworkin; Stewart A Fabb; Jeremy Swann; Grant A McArthur; Susan V Westmoreland; Pierre Chambon; David T Scadden; Louise E Purton
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

6.  Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.

Authors:  Helene Hartvedt Grytli; Morten Wang Fagerland; Sophie D Fosså; Kristin Austlid Taskén
Journal:  Eur Urol       Date:  2013-01-14       Impact factor: 20.096

7.  Autonomic nerve development contributes to prostate cancer progression.

Authors:  Claire Magnon; Simon J Hall; Juan Lin; Xiaonan Xue; Leah Gerber; Stephen J Freedland; Paul S Frenette
Journal:  Science       Date:  2013-07-12       Impact factor: 47.728

8.  Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis.

Authors:  Teresa L Ramos; Luis Ignacio Sánchez-Abarca; Beatriz Rosón-Burgo; Alba Redondo; Ana Rico; Silvia Preciado; Rebeca Ortega; Concepción Rodríguez; Sandra Muntión; Ángel Hernández-Hernández; Javier De Las Rivas; Marcos González; José Ramón González Porras; Consuelo Del Cañizo; Fermín Sánchez-Guijo
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

9.  Notch-dependent repression of miR-155 in the bone marrow niche regulates hematopoiesis in an NF-κB-dependent manner.

Authors:  Lin Wang; Huajia Zhang; Sonia Rodriguez; Liyun Cao; Jonathan Parish; Christen Mumaw; Amy Zollman; Malgorzata M Kamoka; Jian Mu; Danny Z Chen; Edward F Srour; Brahmananda R Chitteti; Harm HogenEsch; Xiaolin Tu; Teresita M Bellido; H Scott Boswell; Taghi Manshouri; Srdan Verstovsek; Mervin C Yoder; Reuben Kapur; Angelo A Cardoso; Nadia Carlesso
Journal:  Cell Stem Cell       Date:  2014-07-03       Impact factor: 24.633

Review 10.  Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Authors:  Guanxi Qiao; Minhui Chen; Mark J Bucsek; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Front Immunol       Date:  2018-02-06       Impact factor: 7.561
View more
  3 in total

Review 1.  Inflammatory Microenvironment and Specific T Cells in Myeloproliferative Neoplasms: Immunopathogenesis and Novel Immunotherapies.

Authors:  Vincenzo Nasillo; Giovanni Riva; Ambra Paolini; Fabio Forghieri; Luca Roncati; Beatrice Lusenti; Monica Maccaferri; Andrea Messerotti; Valeria Pioli; Andrea Gilioli; Francesca Bettelli; Davide Giusti; Patrizia Barozzi; Ivana Lagreca; Rossana Maffei; Roberto Marasca; Leonardo Potenza; Patrizia Comoli; Rossella Manfredini; Antonino Maiorana; Enrico Tagliafico; Mario Luppi; Tommaso Trenti
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923

Review 2.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

Review 3.  Bone marrow niche dysregulation in myeloproliferative neoplasms.

Authors:  Natalia Curto-Garcia; Claire Harrison; Donal P McLornan
Journal:  Haematologica       Date:  2020-04-02       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.